Evaluation of Blood Protein O-GlcNAcylation Levels in Children
A legfontosabb adatok
- Ki végzi
- Nantes University Hospital
- Hol
- Franciaország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 240 fő, tervezett
- Kezdés
- 2025. jan. 30.
- Várható befejezés
- 2036. jan. 31.
- A vizsgálat típusa
- Megfigyeléses, 2 csoport
- A regiszteradat frissítve
- 2026. november 12.
Ki vehet részt
- Életkor
- Legfeljebb 17 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 28 feltétel megnézéseKevesebb
Ki vehet részt
- Age from 0 to 17 years at the time of sampling (including premature infants)
- Children coming to hospital for a blood sample to be taken as part of a pre-operative check-up, an allergy check-up or a check-up as part of a pathology other than sepsis
- Premature infants benefiting from a blood sample as part of their monitoring and management of prematurity
- Collection of umbilical cord blood
- Signed consent
- Age from 0 to 17 years at the time of sampling (including preterm infants)
- Children with suspected sepsis or diagnosed sepsis according to the 2016 definition
- Premature infants having blood drawn for suspected or diagnosed sepsis
- All responsible bacteria, viruses or fungi
- Signed bio-collection consent
Ki nem vehet részt
- Children with an infection
- Children with autoimmune disease
- Children with metabolic disease
- Children with haematological diseases
- Children with a genetic disease
- Children with autoimmune disease
- Children with a metabolic disease
- Children with haematological diseases
- Children with a genetic disease
- Children with fever
- Children with an immune deficiency
- Unsigned consent
- Refusal by parents or child
- Septic group
- Children with an immune deficiency
- Unsigned bio-collection consent
- Refusal by parents or child
Egyéb feltételek
- Healthy group
Ez a vizsgálat jelenleg itt érhető el: Franciaország.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Stimulation of O-GlcNAcylation has been shown to be beneficial in several acute pathologies and different animal models, such as haemorrhagic and septic shock, and ischaemia-reperfusion (cerebral and cardiac). It could therefore be interesting to use this approach in children in order to limit the impact of various pathologies inducing SIRS, such as extracorporeal circulation for major surgery, septic shock or various traumas. The investigators demonstrated in 2 different animal models (endotoxemia by injection of Lipopolysaccharides and caecal puncture ligation model) with 3 different pharmacological molecules (Glucosamine, ThiametG and NButGT) that stimulation of O-GlcNAcylation was beneficial in the early phase of septic shock with a marked effect on cardiac function and survival. The investigators thus demonstrated that stimulation of O-GlcNAcylation was beneficial in young rats in septic shock. However, none of this work has yet been reproduced in humans, either children or adults.
A vizsgálat 2 csoportja
- Healthy group
children attending hospital and receiving a blood sample as part of their care during general paediatric consultations, anaesthesia or day hospital consultations. Children requiring a blood test as part of a medical indication in the first week of life / blood samples taken at birth from cord blood. A blood sample will be taken at inclusion during a blood test carried out in the care unit, and possibly if other blood samples are planned as part of the care, additional samples will be taken in a maximum of 6 tubes in 48 hours, i.e. for a total volume of 600 µl to 3 ml. The child's clinical data will be collected in his medical file.
- Septic shock
Children attending a paediatric emergency department for a severe infection requiring vascular filling, or a child admitted to an intensive care unit for sepsis or presenting with sepsis during hospitalisation. A blood sample will be taken at inclusion during a blood test carried out in the care unit and then at H3, H6, H12, H24 and H48, i.e. 6 times in 48 hours for a total volume of 600 µl to 3 ml for patients in septic shock. The child's clinical data will be collected in his medical file.
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Evaluation of Blood Protein O-GlcNAcylation Levels in Children - CHANCE Study (Child Heart O-glcnAc Nantes)
- A regiszteradat frissítve
- 2026. november 12.